Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9075)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 21, 2014 (publication date) through Apr 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ferro R, Falasca M. Emerging role of the KRAS-PDK1 axis in pancreatic cancer. World J Gastroenterol 2014; 20(31): 10752-10757 [PMID: 25152578 DOI: 10.3748/wjg.v20.i31.10752] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i31/10752.htm |
| Number | Citing Articles |
| 1 |
Aikaterini Emmanouilidi, Marco Falasca. Encyclopedia of Signaling Molecules. 2018; : 12 doi: 10.1007/978-3-319-67199-4_101748
|
| 2 |
Helen King, Kiruthikah Thillai, Andrew Whale, Prabhu Arumugam, Hesham Eldaly, Hemant M. Kocher, Claire M. Wells. PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration. Scientific Reports 2017; 7(1) doi: 10.1038/srep42575
|
| 3 |
Mohammad Khan, Shafquat Azim, Haseeb Zubair, Arun Bhardwaj, Girijesh Patel, Moh’d Khushman, Seema Singh, Ajay Singh. Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward. International Journal of Molecular Sciences 2017; 18(4): 779 doi: 10.3390/ijms18040779
|
| 4 |
Aikaterini Emmanouilidi, Marco Falasca. Targeting PDK1 for Chemosensitization of Cancer Cells. Cancers 2017; 9(10): 140 doi: 10.3390/cancers9100140
|
| 5 |
Simona Sestito, Simona Daniele, Giulia Nesi, Elisa Zappelli, Danilo Di Maio, Luciana Marinelli, Maria Digiacomo, Annalina Lapucci, Claudia Martini, Ettore Novellino, Simona Rapposelli. Locking PDK1 in DFG-out conformation through 2-oxo-indole containing molecules: Another tools to fight glioblastoma. European Journal of Medicinal Chemistry 2016; 118: 47 doi: 10.1016/j.ejmech.2016.04.003
|
| 6 |
Shaila A. Shetu, Nneoma James, Gildardo Rivera, Debasish Bandyopadhyay. Molecular Research in Pancreatic Cancer: Small Molecule Inhibitors, Their Mechanistic Pathways and Beyond. Current Issues in Molecular Biology 2023; 45(3): 1914 doi: 10.3390/cimb45030124
|
| 7 |
Eros Di Giorgio, Annalisa Ferino, Himanshi Choudhary, Phillip M.G. Löffler, Francesca D'Este, Valentina Rapozzi, Alexander Tikhomirov, Andrey Shchekotikhin, Stefan Vogel, Luigi E. Xodo. Photosensitization of pancreatic cancer cells by cationic alkyl-porphyrins in free form or engrafted into POPC liposomes: The relationship between delivery mode and mechanism of cell death. Journal of Photochemistry and Photobiology B: Biology 2022; 231: 112449 doi: 10.1016/j.jphotobiol.2022.112449
|
| 8 |
K. Sri Manjari, Srilekha Avvari, Imran Ali Khan, DKV Prasad. Role of MicroRNAs in Cancers. 2022; : 13 doi: 10.1007/978-981-16-9186-7_2
|
| 9 |
Manmeet Rawat, Kavita Kadian, Yash Gupta, Anand Kumar, Patrick S.G. Chain, Olga Kovbasnjuk, Suneel Kumar, Gulshan Parasher. MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential. Genes 2019; 10(10): 752 doi: 10.3390/genes10100752
|
| 10 |
Aikaterini Emmanouilidi, Chanse A. Fyffe, Riccardo Ferro, Charlotte E. Edling, Emily Capone, Simona Sestito, Simona Rapposelli, Rossano Lattanzio, Stefano Iacobelli, Gianluca Sala, Tania Maffucci, Marco Falasca. Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1191-2
|
| 11 |
Chiara Birtolo, Vay Liang W. Go, Andrzej Ptasznik, Guido Eibl, Stephen J. Pandol. Phosphatidylinositol 3-Kinase. Pancreas 2016; 45(1): 21 doi: 10.1097/MPA.0000000000000531
|
| 12 |
Marco Falasca, Minkyoung Kim, Ilaria Casari. Pancreatic cancer: Current research and future directions. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2016; 1865(2): 123 doi: 10.1016/j.bbcan.2016.01.001
|
| 13 |
Jian-ying Tang, Tu Dai, Hui Zhang, Wu-jun Xiong, Ming-zheng Xu, Xu-jing Wang, Qing-he Tang, Bo Chen, Ming Xu. GDC-0980-induced apoptosis is enhanced by autophagy inhibition in human pancreatic cancer cells. Biochemical and Biophysical Research Communications 2014; 453(3): 533 doi: 10.1016/j.bbrc.2014.09.115
|
| 14 |
Maria Mortoglou, David Wallace, Aleksandra Buha Djordjevic, Vladimir Djordjevic, E. Damla Arisan, Pinar Uysal-Onganer. MicroRNA-Regulated Signaling Pathways: Potential Biomarkers for Pancreatic Ductal Adenocarcinoma. Stresses 2021; 1(1): 30 doi: 10.3390/stresses1010004
|
| 15 |
Suhong Zhang, Haiting Dai, Wenya Li, Runming Wang, Hanyu Wu, Ming Shen, Ye Hu, Lixin Xie, Yiming Xing. TMEM116 is required for lung cancer cell motility and metastasis through PDK1 signaling pathway. Cell Death & Disease 2021; 12(12) doi: 10.1038/s41419-021-04369-1
|
| 16 |
Alina Doctor, Verena Seifert, Martin Ullrich, Sandra Hauser, Jens Pietzsch. Three-Dimensional Cell Culture Systems in Radiopharmaceutical Cancer Research. Cancers 2020; 12(10): 2765 doi: 10.3390/cancers12102765
|
| 17 |
Zhonglu Yang, Zhiyi Wu, Tao Liu, Lei Han, Chunhui Wang, Bo Yang, Fei Zheng. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro. Medical Oncology 2014; 31(12) doi: 10.1007/s12032-014-0337-5
|
| 18 |
Nana Zheng, Jiaqi Wei, Depei Wu, Yang Xu, Jianping Guo. Master kinase PDK1 in tumorigenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878(6): 188971 doi: 10.1016/j.bbcan.2023.188971
|
| 19 |
Dingyuan Luo, Xinke Xu, Junliang Li, Cheng Chen, Wei Chen, Fangyu Wang, Yanping Xie, Fangcheng Li. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4525
|
| 20 |
Defeng Sun, Haoyi Jin, Jun Zhang, Xiaodong Tan. Integrated whole genome microarray analysis and immunohistochemical assay identifies COL11A1, GJB2 and CTRL as predictive biomarkers for pancreatic cancer. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0669-x
|
| 21 |
Ilaria Casari, Alice Domenichini, Simona Sestito, Emily Capone, Gianluca Sala, Simona Rapposelli, Marco Falasca. Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony Formation. Cancers 2019; 11(11): 1695 doi: 10.3390/cancers11111695
|
| 22 |
Naiwang Tang, Bin Hu, Yin Zhang, Zhiwei Chen, Ronghuan Yu. Possible involvement of the Hedgehog and PDPK1–Akt pathways in the growth and migration of small-cell lung cancer. Journal of International Medical Research 2021; 49(5) doi: 10.1177/03000605211016562
|
| 23 |
Victor-Bogdan Popescu, Krishna Kanhaiya, Dumitru Iulian Năstac, Eugen Czeizler, Ion Petre. Network controllability solutions for computational drug repurposing using genetic algorithms. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-05335-3
|
| 24 |
Keiichi Yonemori, Hiroshi Kurahara, Kosei Maemura, Shoji Natsugoe. MicroRNA in pancreatic cancer. Journal of Human Genetics 2017; 62(1): 33 doi: 10.1038/jhg.2016.59
|
| 25 |
Wenming Zhang, Zheng Xu, Yunyan Du, Tiande Liu, Zhijuan Xiong, Junwen Hu, Leifeng Chen, Xiaogang Peng, Fan Zhou. Identification of STAM-binding protein as a target for the treatment of gemcitabine resistance pancreatic cancer in a nutrient-poor microenvironment. Cell Death & Disease 2024; 15(9) doi: 10.1038/s41419-024-07048-z
|
| 26 |
Paolo Armando Gagliardi, Alberto Puliafito, Luca Primo. PDK1: At the crossroad of cancer signaling pathways. Seminars in Cancer Biology 2018; 48: 27 doi: 10.1016/j.semcancer.2017.04.014
|
| 27 |
Zining Zhang, Heng Zhang, Xiang Liao, Hsiang-i Tsai. KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1147676
|
| 28 |
Ismail M. Meraz, Mourad Majidi, Bingliang Fang, Feng Meng, Lihui Gao, RuPing Shao, Renduo Song, Feng Li, Yonathan Lissanu, Huiqin Chen, Min Jin Ha, Qi Wang, Jing Wang, Elizabeth Shpall, Sung Yun Jung, Franziska Haderk, Philippe Gui, Jonathan Wesley Riess, Victor Olivas, Trever G. Bivona, Jack A. Roth. 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib. Communications Biology 2023; 6(1) doi: 10.1038/s42003-023-04889-w
|
| 29 |
Xiaoyun Wang, Christina R. Chow, Kazumi Ebine, Jiyoung Lee, Marsha R. Rosner, Tao Pan, Hidayatullah G. Munshi. Interaction of tRNA with MEK2 in pancreatic cancer cells. Scientific Reports 2016; 6(1) doi: 10.1038/srep28260
|
| 30 |
Katharina Hütz, Julian Zeiler, Lena Sachs, Steffen Ormanns, Volker Spindler. Loss of desmoglein 2 promotes tumorigenic behavior in pancreatic cancer cells. Molecular Carcinogenesis 2017; 56(8): 1884 doi: 10.1002/mc.22644
|
| 31 |
Oskar Przybyszewski, Michał Mik, Michał Nowicki, Michał Kusiński, Melania Mikołajczyk-Solińska, Agnieszka Śliwińska. Using microRNAs Networks to Understand Pancreatic Cancer—A Literature Review. Biomedicines 2024; 12(8): 1713 doi: 10.3390/biomedicines12081713
|
| 32 |
Zhichao Sun, Lei Xu. Expression of PDK‑1 and DMBT1 in the thyroid carcinoma and its clinicopathological significance. Oncology Letters 2019; doi: 10.3892/ol.2019.10639
|
| 33 |
Aikaterini Emmanouilidi, Marco Falasca. Encyclopedia of Signaling Molecules. 2016; : 1 doi: 10.1007/978-1-4614-6438-9_101748-1
|
| 34 |
Simona Sestito, Simona Rapposelli. A patent update on PDK1 inhibitors (2015-present). Expert Opinion on Therapeutic Patents 2019; 29(4): 271 doi: 10.1080/13543776.2019.1597852
|